Serge Belanger analyst NEEDHAM

Currently out of the existing stock ratings of Serge Belanger, 298 are a BUY (94.6%), 17 are a HOLD (5.4%).

Serge Belanger

Work Performance Price Targets & Ratings Chart

Analyst Serge Belanger works at NEEDHAM with a stock forecast success ratio of 25.85% fulfilled within 174.84 days on average.

Serge Belanger’s has documented 611 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CYTK, Cytokinetics at 23-May-2024.

Wall Street Analyst Serge Belanger

Analyst best performing recommendations are on GRAY (GRAYBUG VISION).
The best stock recommendation documented was for KALV (KALVISTA PHARMACEUTICALS) at 1/26/2021. The price target of $32 was fulfilled within 14 days with a profit of $15.65 (95.72%) receiving and performance score of 68.37.

Average potential price target upside

AMPH Amphastar P CLSD Clearside Biomedical COLL Collegium Pharmaceutical CORI Corium International FLXN Flexion Therapeutics HRTX Heron Therapeuti KALV Kalvista Pharmaceuticals LQDA Liquidia Technologies OMER Omeros PCRX Pacira Pharmaceuticals RVNC Revance The VRCA Verrica Pharmaceuticals ZGNX Zogenix AERI Aerie Pharmaceuticals . AKBA Akebia Ther BCRX BioCryst Pharmaceuticals CRXT Clarus Therapeutics Holdings CYTK Cytokinetics GRAY Graybug Vision PHAS PhaseBio Pharmaceuticals TCDA Tricida TRVI Trevi Therapeutics XENE Xenon Pharmaceuticals ESPR Esperion Therapeutics PTX Pernix Therapeutics Holdings CRMD CorMedix AMAG AMAG Pharmaceuticals ARQT Arcutis Biotherapeutics  EOLS Evolus VRDN Viridian Therapeutics ZYNE Zynerba Pharmaceuticals DICE Dice Molecules Holdings LLC MLTX MoonLake Immunotherapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

71

$27.74 (64.12%)

41

9 months 17 days ago

10/11 (90.91%)

$8.79 (14.13%)

337

Buy

70

$26.74 (61.81%)

44

10 months 1 days ago

2/3 (66.67%)

$8.35 (13.54%)

105

Hold

44

$0.74 (1.71%)

40

1 years 9 days ago

5/5 (100%)

$1.03 (2.40%)

86

Buy

33

$-25.16 (-43.26%)

24

2 years 2 months 15 days ago

3/3 (100%)

$-1.3 (-3.79%)

375

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Serge Belanger is most bullish on?

Potential upside of $25.15 has been obtained for MLTX (MOONLAKE IMMUNOTHERAPEUTICS)

Which stock is Serge Belanger is most reserved on?

Potential downside of -$0 has been obtained for OMER (OMEROS)

What Year was the first public recommendation made by Serge Belanger?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?